Table 3.
Clinical pain and psychological measures across the clusters adjusted for race and study site.
| Cluster 1 Higher Function Minimal Movement-Evoked Pain (n=145) |
Cluster 2 Moderate Function Mild Movement- Evoked Pain (n=101) |
Cluster 3 Lower Function Severe Movement- Evoked Pain (n=24) |
Adju sted p- value |
|
|---|---|---|---|---|
| Characteristic Pain Intensity, mean ± SD | 41.8 ± 20.0 | 57.5 ± 18.2 | 79.2 ± 11.6 | <0.0001 |
| WOMAC-Pain, mean ± SD | 5.4 ± 3.4 | 8.6 ± 3.5 | 13.2 ± 3.3 | <0.0001 |
| WOMAC- Stiffness, mean ± SD | 2.8 ± 0.7 | 3.9 ± 0.8 | 5.5 ± 1.0 | <0.0001 |
| WOMAC-Function, mean ± SD | 17.8 ± 11.9 | 27.6 ± 12.6 | 42.0 ± 10.5 | <0.0001 |
| # of Pain Sites, mean ± SD | 4.5 ± 3.8 | 5.8 ± 3.7 | 9.0 ± 4.8 | <0.0001 |
| # of Pain Days Past 6 mo., mean ± SD | 7.5 ± 14.8 | 20.7 ± 38.9 | 40.3 ± 56.9 | <0.0001 |
| CES-D, mean ± SD | 8.2 ± 6.7 | 10.8 ± 7.9 | 12.9 ± 7.2 | 0.003 |
| CSQ- Active Coping, mean ± SD | 2.7 ± 0.9 | 3.2 ± 0.9 | 3.4 ± 1.0 | 0.001 |
| CSQ- Passive Coping, mean ± SD | 2.8 ± 1.2 | 2.9 ± 1.1 | 3.6 ± 1.0 | 0.004 |
| CSQ- Catastrophizing, mean ± SD | 1.5 ± 0.9 | 1.7 ± 1.1 | 2.4 ± 1.2 | <0.0001 |
| PVAQ, mean ± SD | 44.6 ± 14.7 | 45.4 ± 13.7 | 56.3 ± 10.3 | <0.0001 |
| Positive Affect, mean ± SD | 35.4 ± 7.5 | 35.6 ± 7.8 | 36.4 ± 8.7 | 0.832 |
| Negative Affect, mean ± SD | 13.7 ± 4.6 | 15.7 ± 6.5 | 15.1 ± 6.5 | 0.050 |